Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Emerging as a promising therapeutic target, hepsin holds potential for combination therapy with N-acetylcysteine, paving the way for novel approaches in managing drug-induced liver injury
Seven more large-scale trials (the TRIUMPH program, over 5,800 people total) are still running and will release results throughout 2026
Tendinopathy-from basic science to treatment
Peripheral artery disease pain symptoms : A study found that an intravenous glutathione supplement helped ease pain in people who had decreased blood flow to their legs due to vascular disease
It also improves deep sleep quality, increases daytime energy levels, supports tissue repair after physical stress, improves skin elasticity through collagen support, and helps maintain bone density
